Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

💥 What if an immune cell could defend the body by literally exploding? A fascinating new study in Cell describes “ruptoblasts,” a previously unknown cytotoxic cell type in planarian flatworms. Triggered by activin signaling, these cells undergo an explosive form of death called ruptosis, releasing potent diffusible factors that rapidly kill nearby cells and bacteria. 🧬⚡ The work links hormone surveillance with immune defense and uncovers a mechanism distinct from apoptosis, pyroptosis, necroptosis, and ferroptosis. A remarkable glimpse into ancient evolutionary solutions to...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

📱❤️ Can your smartphone become a heart monitor?   A landmark Nature study demonstrates that passive heart-rate monitoring using a smartphone’s front-facing camera can accurately measure heart rate and resting heart rate during everyday phone use—without a wearable device. The AI-powered system achieved industry accuracy standards across diverse skin tones and showed strong correlation with cardiovascular fitness and obesity risk factors.   This work may democratize heart-health monitoring for billions worldwide. 🌍💓   #Cardiology #DigitalHealth #AIinMedicine...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🍷 How much alcohol is truly safe?   A landmark Burden of Proof study published in Nature Health analyzed 843 cohort and case-control studies examining alcohol and 20 major health outcomes.   Key findings: ✅ Even low levels of alcohol increased the risk of several cancers. ✅ Higher alcohol intake increased risk across all outcomes studied. ✅ Low-to-moderate intake showed possible associations with lower risks of type 2 diabetes, dementia, and some cardiovascular diseases—but these findings remain observational and uncertain.   The takeaway: alcohol’s health effects...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🏮⚕️ More than 2,300 years ago, the legendary Chinese physician Bian Que (Qin Yueren) taught a lesson that remains central to medicine today: detect disease early.   Known for his four-step diagnostic method—Looking 👁️, Listening 👂, Inquiring 💬, and Taking the Pulse ❤️—Bian Que emphasized careful observation and individualized care long before modern diagnostic technology existed.   His famous story of warning the Lord of Cai illustrates a timeless truth: diseases are easiest to treat before symptoms become severe.   Whether history, legend, or a blend...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🧠 Alzheimer’s disease remains the leading cause of dementia worldwide, but the field is changing rapidly.   New advances in genetics, blood-based biomarkers, amyloid and tau PET imaging, and disease-modifying therapies are transforming how we diagnose and manage this devastating condition. From APOE genetics to plasma p-tau217 and anti-amyloid treatments, we are entering an era of earlier detection and more personalized care.   🎙️ In Dr RR Baliga’s Podkast for the Curious Doc, we explore the science, clinical implications, and future directions of Alzheimer’s disease....

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🩺💊 Which blood pressure medications do patients tolerate best?   A major JAMA network meta-analysis of 716 randomized trials involving 159,362 participants found important differences in adverse effects and treatment discontinuation across antihypertensive regimens.   🏆 ARB + CCB combinations ranked as the most tolerated therapy. ✅ ARB-containing regimens consistently performed best. ⚠️ CCBs were associated with more edema and treatment discontinuation. ⚠️ ACE inhibitors remained the leading cause of cough.   The message is clear: tolerability influences...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🧬 Aging leaves a molecular fingerprint—and we can now read it.   A remarkable Nature study analyzed >11,000 transcriptomes across mice, rats, macaques, and humans to identify universal transcriptomic hallmarks of ageing. The investigators developed highly accurate gene-expression clocks that predict biological age, mortality risk, lifespan modulation, and responses to rejuvenation interventions.   Key themes included inflammation, interferon signaling, mitochondrial dysfunction, chromatin remodeling, and extracellular matrix changes. Notably, CDKN1A (p21) and LGALS3 emerged...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🫀 Coronary microvascular dysfunction is no longer a “hidden” diagnosis.   The new FLOW-CMD Registry published in The Lancet demonstrates that coronary microvascular dysfunction frequently coexists with obstructive coronary artery disease and significantly increases adverse cardiovascular outcomes.   Patients with CMD had: ⚠️ Higher cardiac death ⚠️ More repeat revascularization ⚠️ Increased heart failure hospitalization risk   This study reminds us that ischemic heart disease is more than epicardial stenosis alone. Coronary physiology — CFR, IMR, and FFR —...

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🫀 Fascinating new study in the The New England Journal of Medicine explores “Stem-Cell–Derived Biologic Ventricular Assist Tissue (BioVAT)” for advanced heart failure. Investigators demonstrated that engineered heart-muscle patches derived from induced pluripotent stem cells increased ventricular wall thickness, modestly improved left ventricular ejection fraction, and enhanced quality of life in patients with severe heart failure.   This may represent an important step toward true cardiac remuscularization — moving beyond support devices toward biologic repair itself....

Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!

🧬 Could a single infusion replace decades of lipid-lowering therapy?   The new NEJM study on VERVE-102 explores in vivo base editing of PCSK9 using CRISPR-inspired adenine base editing technology. In this phase 1 trial, a one-time infusion produced LDL cholesterol reductions up to 62% with durable effects extending beyond 1 year. ❤️   This may represent a major shift from chronic pharmacotherapy toward “once-and-done” genomic cardiovascular prevention.   The science, safety, clinical implications, and future of gene-editing cardiology on “Dr RR Baliga’s Podkast...